Karyopharm Therapeutics Inc (KPTI)
0.7776
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
0.7699
-0.01
(-0.99%)
After-Hours: 20:00
Karyopharm Therapeutics Debt to Equity Ratio: -1.194 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.194 |
| June 30, 2024 | -1.446 |
| March 31, 2024 | -1.013 |
| December 31, 2023 | -1.255 |
| September 30, 2023 | -1.700 |
| June 30, 2023 | -2.393 |
| March 31, 2023 | -3.77 |
| December 31, 2022 | -10.21 |
| September 30, 2022 | -1.211 |
| June 30, 2022 | -1.459 |
| March 31, 2022 | -2.040 |
| December 31, 2021 | -2.125 |
| September 30, 2021 | -1.342 |
| June 30, 2021 | -2.032 |
| March 31, 2021 | -4.256 |
| December 31, 2020 | 2.333 |
| September 30, 2020 | 1.382 |
| June 30, 2020 | 0.8766 |
| March 31, 2020 | 0.6727 |
| December 31, 2019 | 2.207 |
| September 30, 2019 | 1.803 |
| June 30, 2019 | 1.287 |
| March 31, 2019 | 0.8605 |
| December 31, 2018 | 0.5605 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | |
| December 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-10.21
Minimum
Dec 2022
2.333
Maximum
Dec 2020
-1.499
Average
-1.394
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.271 |
| Ionis Pharmaceuticals Inc | 1.930 |
| Apellis Pharmaceuticals Inc | 1.907 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 189.48M |
| Total Liabilities (Quarterly) | 349.12M |
| Shareholders Equity (Quarterly) | -159.65M |
| Current Ratio | 3.004 |
| Net Debt Paydown Yield | -3.86% |